131 related articles for article (PubMed ID: 37414038)
41. Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications.
Chang J; Schomer D; Dragovich T
Biomed Res Int; 2015; 2015():269641. PubMed ID: 26146615
[TBL] [Abstract][Full Text] [Related]
42. Self-assembled polymeric nanoparticles as new, smart contrast agents for cancer early detection using magnetic resonance imaging.
Mouffouk F; Simão T; Dornelles DF; Lopes AD; Sau P; Martins J; Abu-Salah KM; Alrokayan SA; Rosa da Costa AM; dos Santos NR
Int J Nanomedicine; 2015; 10():63-76. PubMed ID: 25565804
[TBL] [Abstract][Full Text] [Related]
43. Response to "The National Lung Screening Trial Premise of Null and Chest Radiography Equivalence Is Open to Question".
Church TR
AJR Am J Roentgenol; 2015 Aug; 205(2):280. PubMed ID: 26204276
[No Abstract] [Full Text] [Related]
44. AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
Fulgham PF; Rukstalis DB; Turkbey IB; Rubenstein JN; Taneja S; Carroll PR; Pinto PA; Bjurlin MA; Eggener S
J Urol; 2017 Oct; 198(4):832-838. PubMed ID: 28483574
[TBL] [Abstract][Full Text] [Related]
45. Breast magnetic resonance imaging for surveillance of women with a personal history of breast cancer: outcomes stratified by interval between definitive surgery and surveillance MR imaging.
Park VY; Kim EK; Kim MJ; Moon HJ; Yoon JH
BMC Cancer; 2018 Jan; 18(1):91. PubMed ID: 29357842
[TBL] [Abstract][Full Text] [Related]
46. Response.
Kuhl C; Strobel K
Radiology; 2015 Nov; 277(2):612-3. PubMed ID: 26793796
[No Abstract] [Full Text] [Related]
47. Clinical Utility of 4Kscore
de la Calle CM; Fasulo V; Cowan JE; Lonergan PE; Maggi M; Gadzinski AJ; Yeung RA; Saita A; Cooperberg MR; Shinohara K; Carroll PR; Nguyen HG
J Urol; 2021 Feb; 205(2):452-460. PubMed ID: 32897802
[TBL] [Abstract][Full Text] [Related]
48. Challenges in Adopting Level 1 Evidence for Multiparametric Magnetic Resonance Imaging as a Biomarker for Prostate Cancer Screening.
Kim SJ; Vickers AJ; Hu JC
JAMA Oncol; 2018 Dec; 4(12):1663-1664. PubMed ID: 30242308
[No Abstract] [Full Text] [Related]
49. Biomarkers for early detection of liver cancer: focus on clinical evaluation.
Sun S; Day PJ; Lee NP; Luk JM
Protein Pept Lett; 2009; 16(5):473-8. PubMed ID: 19442225
[TBL] [Abstract][Full Text] [Related]
50. [Contribution of magnetic resonance imaging in diagnosis of pericardial mesothelioma: a case report].
Nana A; Vorilhon C; Adjtoutah D; Azarnoush K; Kissel V; Chabin X; Chailloux A; Belhakem A; Tixier V; Ferrier N; Croisille P; Long JL; Marcaggi X
Ann Cardiol Angeiol (Paris); 2012 Nov; 61(5):370-4. PubMed ID: 22959437
[TBL] [Abstract][Full Text] [Related]
51. Diagnosis: A step closer to screening for curable pancreatic cancer?
Canto MI; Hruban RH
Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):431-2. PubMed ID: 26122477
[No Abstract] [Full Text] [Related]
52. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
Fu D; Huang X; Lv Z; Zhang Y; Chen M; Zhang W; Su D
Bioengineered; 2022 Mar; 13(3):7105-7117. PubMed ID: 35259049
[TBL] [Abstract][Full Text] [Related]
53. T1 and T2 Mapping for Early Detection of Treatment-Related Myocardial Changes in Breast Cancer Patients.
Kvernby S; Flejmer AM; Dasu A; Bolger AF; Ebbers T; Engvall JE
J Magn Reson Imaging; 2022 Feb; 55(2):620-622. PubMed ID: 34231931
[No Abstract] [Full Text] [Related]
54. MRI-Targeted Biopsy in Prostate Cancer Screening.
Yoshida S; Fujii Y
N Engl J Med; 2021 Nov; 385(22):2110. PubMed ID: 34818497
[No Abstract] [Full Text] [Related]
55. MRI-Targeted Biopsy in Prostate Cancer Screening.
Al Hussein Al Awamlh B; Spratt DE; Shoag JE
N Engl J Med; 2021 Nov; 385(22):2109-2110. PubMed ID: 34818496
[No Abstract] [Full Text] [Related]
56. Role of imaging in diagnosis, staging and follow-up of lung cancer.
De Wever W; Verschakelen J; Coolen J
Curr Opin Pulm Med; 2014 Jul; 20(4):385-92. PubMed ID: 24837705
[TBL] [Abstract][Full Text] [Related]
57. Re: Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.
Leveridge M; Siemens DR
Eur Urol; 2022 Oct; 82(4):440. PubMed ID: 35907661
[No Abstract] [Full Text] [Related]
58. Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography-The IP1-PROSTAGRAM Study.
Oong Z; Parikh O
JAMA Oncol; 2021 Oct; 7(10):1575. PubMed ID: 34410313
[No Abstract] [Full Text] [Related]
59. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
[TBL] [Abstract][Full Text] [Related]
60. Imaging of colorectal polyps and early rectal cancer.
Laghi A; Bellini D; Petrozza V; Piccazzo R; Santoro GA; Fabbri C; van der Paardt MP; Stoker J
Colorectal Dis; 2015 Jan; 17 Suppl 1():36-43. PubMed ID: 25511860
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
